Summary:
A 3 month study to determine the effect of an investigative medicine on morning testosterone and reproductive status in men with secondary hypogonadism compared with Testim or placebo.
Qualified Participants Must:
• Be 21 to 64 years of age
•
Diagnosed with low testosterone
•
Have a diagnosis of type II diabetes
Qualified Participants May Receive:
Study related medical care, medication and lab work. You may also be compensated for your participation.